DonaldMarkMillerMD

PubMed

• Genomic c-Myc quadruplex DNA selectively kills leukemia.
  Sedoris, K. C., Thomas, S. D., Clarkson, C. R., Muench, D., Islam, A., Singh, R., Miller, D. M.> ;Mol Cancer Ther. 2012 Jan
• Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma.
  Telang, S., Rasku, M.A., Clem, A.L., Carter, K., Klarer, A.C., Badger, W.R., Milam, R.A., Rai, S.N., Pan, J., Gragg, H., Clem, B.F., McMasters, K.M., Miller, D.M., Che...> ;BMC Cancer. 2011
• gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
  Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., Kendra, K. L., Whit...> ;N Engl J Med. 2011 Jun 2
• Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer.
  Lane, A. N., Fan, T. W., Bousamra, M., Higashi, R. M., Yan, J., Miller, D. M.> ;OMICS. 2011 Mar
• Hypoxia induces differential translation of enolase/MBP-1.
  Sedoris, K. C., Thomas, S. D., Miller, D. M.> ;BMC Cancer. 2010
• Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.
  Rabinowits, G., Bhupalam, L., Miller, D. M., Kloecker, G. H., Laber, D. A.> ;Am J Med Sci. 2010 Feb
• Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study.
  Desai, P. C., Jaglal, M. V., Gopal, P., Ghim, S. J., Miller, D. M., Farghaly, H., Jenson, A. B.> ;Exp Mol Pathol. 2009 Oct 01
• Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary.
  Jaglal, M. V., Laber, D. A., Arnold, F. W., Miller, D. M., Chesney, J. A., Kloecker, G. H.> ;Am J Clin Oncol. 2009 Aug 01
• Metabolic profiling identifies lung tumor responsiveness to erlotinib.
  Fan, T. W., Lane, A. N., Higashi, R. M., Bousamra, M., Kloecker, G., Miller, D. M.> ;Exp Mol Pathol.
• Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM).
  Fan, T. W., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., Miller, D. M.> ;Mol Cancer. 2009 Jun 30
• Prospects for clinical cancer metabolomics using stable isotope tracers.
  Lane, A. N., Fan, T. W., Higashi, R. M., Tan, J., Bousamra, M., Miller, D. M.> ;Exp Mol Pathol.
• Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
  Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., Trent, J. O.> ;Exp Mol Pathol.
• Cancer research at the James Graham Brown Cancer Center, University of Louisville.
  Jenson, B., Eaton, J. W., Miller, D. M.> ;Exp Mol Pathol.
• Digitalis, a targeted therapy for cancer?
  Khan, M. I., Chesney, J. A., Laber, D. A., Miller, D. M.> ;Am J Med Sci.
• Transient T cell depletion causes regression of melanoma metastases.
  Rasku, M. A., Clem, A. L., Telang, S., Taft, B., Gettings, K., Gragg, H., Cramer, D., Lear, S. C., McMasters, K. M., Miller, D. M., Chesney, J.> ;J Transl Med. 2008
• Laryngeal mask airway classic and streamlined pharynx airway liner airway comparison.
  Miller D> ;Anesth. Analg.. 2007-11-01
• Interrogation of the plasma proteome with differential scanning calorimetry.
  Garbett, N. C., Miller, J. J., Jenson, A. B., Miller, D. M., Chaires, J. B.> ;Clin Chem. 2007 Nov
• c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.
  Sedoris, K. C., Thomas, S. D., Miller, D. M.> ;Biochemistry. 2007 Jul 24
• A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma.
  Laber, D. A., Okeke, R. I., Arce-Lara, C., Taft, B. S., Schonard, C. L., McMasters, K. M., Kloecker, G. H., Miller, D. M.> ;J Cancer Res Clin Oncol. 2006 Sep
• Advantages of ProSeal and SLIPA airways over tracheal tubes for gynecological laparoscopies.
  Miller, D. M., Camporota, L.> ;Can J Anaesth. 2006 Feb
• A proposed classification and scoring system for supraglottic sealing airways: a brief review.
  Miller, D. M.> ;Anesth Analg. 2004 Nov
• Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcript.
  Blume, S. W., Miller, D. M., Guarcello, V., Shrestha, K., Meng, Z., Snyder, R. C., Grizzle, W. E., Ruppert, J. M., Gartland, G. L., Stockard, C. R., Jones, D. E., Eman...> ;Exp Cell Res. 2003 Aug 1
• Storage capacities of the laryngeal mask and laryngeal tube compared and their relevance to aspiration risk during positive pressure ventilation.
  Miller, D. M., Light, D.> ;Anesth Analg. 2003 Jun
• Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis.
  Kakar, S. S., Winters, S. J., Zacharias, W., Miller, D. M., Flynn, S.> ;Gene. 2003 Apr 10
• Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin.
  Mi, Y., Thomas, S. D., Xu, X., Casson, L. K., Miller, D. M., Bates, P. J.> ;J Biol Chem. 2003 Mar 7
• Join now to see all